Hydrogen sulfide (H₂S) is a toxic gas that has important regulatory functions. In the colon, H₂S can be produced and detoxified endogenously. Both too little and too much H₂S exposure are associated with inflammatory bowel disease (IBD), a chronic intestinal disease mainly classified as Crohn’s disease (CD) and ulcerative colitis (UC). As the pathogenesis of IBD remains elusive, this study’s aim was to investigate potential differences in the expression of H₂S-metabolizing enzymes in normal aging and IBD. Intestinal mucosal biopsies of 25 adults and 22 children with IBD along with those of 26 healthy controls were stained immunohistochemically for cystathionine-γ-lyase (CSE), 3-mercapto-sulfurtransferase (3-MST), ethylmalonic encephalopathy 1 protein (ETHE1), sulfide:quinone oxidoreductase (SQOR) and thiosulfate sulfurtransferase (TST). Expression levels were calculated by multiplication of the staining intensity and percentage of positively stained cells. Healthy adults showed an overall trend towards lower expression of H₂S-metabolizing enzymes than healthy children. Adults with IBD also tended to have lower expression compared to controls. A similar trend was seen in the enzyme expression of children with IBD compared to controls. These results indicate an age-related decrease in the expression of H₂S-metabolizing enzymes and a dysfunctional H₂S metabolism in IBD, which was less pronounced in children.

Background/Objectives: Dental rehabilitation after extended tumour resection and jaw reconstruction is challenging. The present study aimed to report the prosthetic outcome and quality of life (QoL) in patients with head and neck cancer (HNC) after microvascular alveolar ridge reconstruction. Methods: The prosthetic outcomes of all consecutive patients with HNC who underwent microvascular alveolar ridge reconstruction at the University Hospital Salzburg between 2011 and 2018 were investigated. Oral health-related QoL (OHrQoL) and overall QoL were assessed using the validated Oral Health Impact Profile-49 (OHIP-49) and Short Form-36 questionnaires. Results: During the study period, 115 consecutive patients with head and neck cancer underwent microvascular jaw reconstruction. Among them, 23.3% and 27.4% received conventional tissue-borne prostheses and implant-supported prostheses, respectively, while 48.7% did not undergo dental rehabilitation. The prosthetic outcome was not associated with tumour stage (p = 0.32). Oral health-related quality of life (OHrQoL) was best in patients with implant-supported dental rehabilitation (OHIP-49 median score = 7) and worst in those with conventional removable dentures (OHIP-49 median score = 54). The corresponding OHIP-49 median score for patients who could not undergo dental rehabilitation was 30.5. All Short Form-36 subscale scores were equal to or higher than the malignancy norm scores. Conclusions: After microvascular jaw reconstruction, approximately one-third of the HNC patients received adequate implant-supported dental rehabilitation. However, the risk of dental rehabilitation failure was 50%. The different prosthetic outcomes affected OHrQoL, but not overall QoL.

Objective: Status epilepticus (SE) is the most severe expression of seizures, encompassing both SE with prominent motor symptoms and nonconvulsive SE (NCSE). Ictal–interictal continuum (IIC), an electroencephalographic phenomenon, is characterized by periodic discharges (PD), spike‐and‐waves or sharp‐and‐waves (SW), or lateralized rhythmic delta activity (LRDA). Peri‐ictal magnetic resonance imaging (MRI) abnormalities (PMA) may offer a potential surrogate marker for ictal activity, yet their association with IIC remains unclear. We aimed to investigate the occurrence of PMA in patients with SE and IIC, and to determine the relationship between IIC patterns and PMA through a latent cluster analysis (LCA). Methods: In a prospective cohort study, 223 adult patients diagnosed with SE or IIC underwent electroencephalography (EEG) and MRI within 48 h of diagnosis. Patients were stratified into two groups: the IIC group and SE group. PMA were assessed using the following MRI sequences: diffusion‐weighted imaging, fluid‐attenuated inversion recovery, and arterial spin labeling. LCA was performed to identify classes based on etiology, EEG patterns, and their localization. Results: PMA were as frequent in patients of the IIC group (23/49, 47%) as in patients of the SE group (64/149, 43%, p = .37). In the IIC group, peri‐ictal hyperperfusion was more frequently associated with lower frequency PD/SW (.5–1 Hz; 12/19, 63%), followed by LRDA (4/13, 31%) and higher frequency PD/SW (>1–2.5 Hz; 4/17, 24%). LCA revealed two classes; Class 1, characterized by nonunilateral high‐frequency PD/SW and triggering factors in epilepsy, had fewer PMA (18%) as compared to Class 2, characterized by predominantly unilateral low‐frequency PD/SW and diverse etiologies (50%; odds ratio = 5.79, p = .02). Significance: PMA occurrence in IIC aligned closely with that in SE, suggesting an overlap between IIC and SE and raising the critical question of whether patients with IIC may have NCSE. We propose an etiology‐driven approach for EEG interpretation in IIC, which may enhance diagnostic accuracy and treatment strategies.

Status epilepticus (SE) is a neurologic emergency with possible long-term sequelae, including the development of epilepsy. We aimed to determine whether peri-ictal MRI abnormalities (PMA) are associated with unprovoked seizures after de novo SE. Adults without epilepsy and a first nonhypoxic SE were included from a prospective database of the Christian Doppler University Hospital, Salzburg, Austria. MRI scans performed within 48 hours of SE diagnosis were evaluated for PMA on diffusion-weighted imaging (DWI), T2-weighted fluid-attenuated inversion recovery (FLAIR), and arterial spin labeling (ASL). The outcome was unprovoked seizures, assessed by retrospective review of hospital records and telephone interviews. Cumulative risk of seizures stratified by PMA occurrence (PMA on DWI/FLAIR, hyperperfusion on ASL, no PMA) was evaluated through survival analysis. Multivariable analysis using logistic regression was conducted to assess the influence of PMA, etiology, semiology, and ictal EEG patterns on seizure occurrence. Among 135 patients included (median age 70 [interquartile range (IQR) 58-80] years and 55% female), 43 (32%) experienced seizures during a median follow-up of 23 (IQR 9-39) months. The cumulative seizure probability at 1 and 4 years was 34% (95% CI 17-47) and 61% (95% CI 37-75) in patients with PMA on DWI/FLAIR; 0% and 13% (95% CI 0-29) in patients with hyperperfusion on ASL; and 25% (95% CI 14-34) and 36% (95% CI 19-49) in those without PMA. Other SE features associated with higher seizure risk were treatment refractoriness (odds ratio [OR] 2.93, 95% CI 1.23-6.98, p = 0.02), longer SE duration (OR 1.003, 95% CI 1.001-1.004, p = 0.02), and lateralized periodic discharges on ictal EEG (OR 3.59, 95% CI 1.37-9.83, p = 0.005). In multivariable analysis, PMA on DWI/FLAIR (log-odds 1.23, 95% CI 0.13-2.33, p = 0.03) and remote etiology (log-odds 1.85, 95% CI 0.45-3.25, p = 0.009) were independently associated with increased seizure probability. PMA on DWI or FLAIR were independently linked to a cumulative seizure risk exceeding 60% after de novo SE, consistent with a diagnosis of epilepsy. The findings of our study may help guide long-term treatment decisions in patients with de novo SE.

Background: The selection of suitable patients for the surgical treatment of benign prostatic obstruction (BPO) is a challenge in persons ≥75 years of age. Methods: After a systematic literature search of PubMed, 22 articles were included in this review. Clinical and functional parameters were evaluated statistically. Results: The mean age of the patients was ≥79 years. The mean duration of postoperative catheterization ranged between 2 (d) (ThuLEP, thulium laser enucleation of the prostate) and 4.4 days (TURP, transurethral resection of the prostate). Complication rates ranged between 6% (HoLAP, holmium laser ablation of the prostate) and 34% (PVP, photoselective vaporization of the prostate); the maximum rate of severe complications was 4% (TURP). The mean postoperative maximal urinary flow (Qmax) in mL/sec. ranged between 12.9 mL/sec. (HoLAP) and 19.8 mL/sec (Hol-TUIP, holmium laser transurethral incision of the prostate). The mean quality of life (QoL) score fell from 4.7 ± 0.9 to 1.8 ± 0.7 (HoLEP), from 4.1 ± 0.4 to 1.9 ± 0.8 (PVP), from 5.1 ± 0.2 to 2.1 ± 0.2 (TURP), and from 4 to 1 (ThuVEP, thulium laser vapoenucleation of the prostate). Pearson’s correlation coefficient (r) revealed a positive linear correlation between age and inferior functional outcome (higher postoperative International Prostate Symptom Score (IPSS) [r = 0.4175]), higher overall complication rates (r = 0.5432), and blood transfusions (r = 0.4474) across all surgical techniques. Conclusions: This meta-analysis provides the summary estimates for perioperative and postoperative functional outcome and safety of endoscopic treatment options for BPO in patients ≥ 75 years of age. Of particular importance is that all surgical techniques significantly improve the postoperative quality of life of patients in this age group compared to their preoperative quality of life.

Background: In addition to being highly distressing, chronic migraine headaches are a major socioeconomic challenge. Like other pain syndromes, migraine headaches are associated with psychological and physiological impairments, including sensorimotor and somatosensory deficits. Aim: This study aims to explore whether patients with high-frequency or chronic migraine differ from a healthy population in the areas of laterality recognition (LAT) and facial emotion recognition (FER) and whether there are correlations between these areas and central sensitization of pain and psychological components like stress, depression, anxiety, and alexithymia. Methods: Using a cross-sectional design, individuals with high-frequency or chronic (ICHD classification) migraine (migraine group MG = 45) and healthy individuals (control group CG = 25) were studied using LAT testing (hand, neck, and face); FER testing; and questionnaires, including the Central Sensitization Inventory (CSI) and the Toronto Alexithymia Scale (TAS-20). Results: Data from 70 participants were collected for analysis. Statistically significant differences were found only in the assessment of central sensitization (p < 0.001). Weak to moderate monotonic correlations were found for the MG, especially between alexithymia detection (TAS-20) and facial emotion recognition (FER test). Discussion: The methodological procedure and its accompanying challenges can be seen as limitations of this study. The lack of significant effects must be mentioned, but the selection of the collected questionnaires, the uniform diagnostics, and the statistical processing of a large amount of data represent methodological strengths. Conclusion: The CSI and the TAS-20 could be used in combination with FER to assess chronic migraine. Implementing the described sensorimotor parameters as a therapeutic intervention requires further investigation.